IL22 and liver disorder: Sertorio M et al. demonstrated that high levels of IL-22 can alleviate liver fibrosis and portal hypertension in hepatitis C patients, while IL-22BP (IL-22 binding protein, the physiological inhibitor of IL-22) increases the risk to develop severe fibrosis 55.